LinkOPH

From Ken Rudzinski, Five-Star Wealth Manager, comes valuable insights and practical, timely strategies on a wide range of financial planning topics, including investments, retirement, insurance, taxes and estate planning.It is not unusual for one or more IRAs to be the largest asset in a person’s retirement portfolio. Is this you? It is also commonplace for people to name a revocable trust as the primary beneficiary of the IRA. If this is you, then you need to make sure your trust is a properly-established “see-through” trust. Otherwise, you will be dooming (Read more...)

BOSTON — A phacoemulsification machine with active fluidics enabled surgeons to use high vacuum while reducing cumulative dissipated energy and lens removal time, a clinician told colleagues here. At the American Society of Cataract and Refractive Surgery annual meeting, David Allen, FRCOphth, discussed a study of the Centurion Vision System (Alcon). “The problem with a traditional system is that if you’re going to use a high vacuum, you need to have a high bottle height,” Allen said.

Read more →

BOSTON — Small-incision lenticule extraction safely and predictably corrected vision in patients with spherical myopia, according to a study here. At the American Society of Cataract and Refractive Surgery annual meeting, John F. Doane, MD, elucidated preliminary clinical trial results with the ReLEx femtosecond laser-assisted small-incision lenticule extraction (smile) procedure with the VisuMax femtosecond laser (Carl Zeiss Meditec). “It’s incredibly predictable,” Doane said.

Read more →

BOSTON — Despite diminished visual acuity immediately after surgery, intravitreal placement of combined triamcinolone acetonide and moxifloxacin proved effective in preventing inflammation and cystoid macular edema after cataract surgery, according to a study. Intravitreal delivery of the drug may be a viable alternative to eye drops, M. Stewart Galloway, MD, said at the American Society of Cataract and Refractive Surgery annual meeting. “We know that patient drop compliance is less than optimal.

Read more →

BOSTON — A hydrogel sealant prevented wound leaks after cataract surgery, according to a study presented here. At the American Society of Cataract and Refractive Surgery annual meeting, Terry Kim, MD, discussed results of a multicenter randomized pivotal trial to evaluate ReSure Sealant (Ocular Therapeutix). The U.S. Food and Drug Administration approved the sealant in January. “ReSure Sealant demonstrated not only non-inferiority but superiority in prevention of fluid egress from these wounds that had demonstrated wound leak and had very few adverse events,” Kim said.

Read more →